Kristin Beltz is a prominent inventor based in Cedar Rapids, IA (US). She has made significant contributions to the field of genome editing, holding a total of 5 patents. Her work focuses on enhancing DNA cleavage activity and improving the efficiency of high-fidelity DNA polymerases.

Latest Patents

Kristin's latest patents include innovative methods using novel CPF1 mutations that enhance the DNA cleavage activity of Cas12a (Cpf1). This patent discusses polynucleotides and amino acids of Cas12a and their applications for genome editing in eukaryotic cells. Another notable patent involves RNASE H2 mutants that reduce primer dimers and off-target amplification in RHPCR-based amplicon sequencing. This invention pertains to hybrid RNase H2 proteins that improve mismatch discrimination and activity in a high-fidelity DNA polymerase buffer.

Career Highlights

Kristin currently works at Integrated DNA Technologies, Inc., where she continues to push the boundaries of genetic research and innovation. Her expertise in molecular biology and genetics has positioned her as a key player in the development of advanced genome editing techniques.

Collaborations

Kristin collaborates with esteemed colleagues, including Mark Aaron Behlke and Scott Rose, who contribute to her research endeavors and enhance the impact of her inventions.

Conclusion

Kristin Beltz is a trailblazer in the field of genome editing, with a strong portfolio of patents that reflect her innovative spirit and dedication to advancing genetic technologies. Her contributions are paving the way for future breakthroughs in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.